top of page
(305) 392-0279
All Posts
PCRI Celebrates FDA Approval of XOCOVA®
Premier Clinical Research Institute Celebrates FDA Approval of XOCOVA®, the first and only oral medication approved in the United States to help prevent COVID-19 following exposure.
D. Chamorro
Aug 41 min read
PREMIER CLINICAL RESEARCH INSTITUTE LEADS COMMUNITY SUPPORT EFFORT FOR DE HOSTOS SENIOR CENTER
PCRI leads community support effort for De Hostos Senior Center, and the launch of #OIDForSeniors
D. Chamorro
Jul 91 min read
Premier clinical Research Institute walks for Mental health at Namiwalks Miami 2026
Premier Clinical Research Institute team participates in NAMI Walks Miami to spread awareness about mental health research.
D. Chamorro
May 192 min read
PCRI Contributes to the First FDA Approval of a Non-Antipsychotic Drug to Treat Agitation in Dementia
The first Non-Antipsychotic Drug to Treat Agitation in Dementia, by Axsome Therapeutics, has been approved by the FDA, and we are so proud to have been a part of contributing to this groundbreaking approval. Premier Clinical Research Institute was one of the contributing research sites that provided valuable data to the clinical trials that eventually led to the FDA's approval of the medication, Auvelity for this condition. Auvelity was already FDA-approved as an oral antidep
D. Chamorro
May 112 min read
bottom of page